PMA device
Intersect Ent Propel Mini Sinus Implant
Intersect Ent. · Drug-Eluting Sinus Stent (OWO, Class III) · First FDA decision Jan 31, 2014, newest Jan 31, 2014Chronic sinusitis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Ent Propel Mini"
MAUDE reports
0
Brand "Ent Propel Mini", since 2015
PubMed studies
0
Mentioning "Ent Propel Mini"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Intersect Ent Propel Mini Sinus Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- INTERSECT ENT PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S012 · Decided Jan 31, 2014 · 123 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ent Propel Mini", any status and sponsor, newest update first.
MedtronicPublic (MDT)
NCT06671561 · 0 participants · Start Jan 30, 2025 · Primary completion Aug 2026
Device: Observational data collection from patients with chronic rhinosinusitis (CRS) receiving PROPEL sinus implant(s) following functional endoscopic sinus surgery (FESS) · For: Chronic Rhinosinusitis (CRS)
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ent Propel Mini", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OWO
36 reports: 7 malfunction, 29 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ent Propel Mini"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OWO.
- PropelIntersect Ent. · PMA 2020
- Propel Mini Sinus ImplantIntersect Ent. · PMA 2016
- Propel Contour Sinus ImplantIntersect Ent. · PMA 2017
- Intersectent Propel Mini Sinus ImplantIntersect Ent. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.